Keep yourself updated about Hikma

Hikma products

Hikma develops, manufactures and markets pharmaceutical products in key therapeutic areas.

Our strengths

Hikma has a strong market position in its core MENA markets.

Our partners
View our partners or find business development contacts

Strong marketing and sales capabilities

Hikma’s powerful combination of quality products and extensive sales and marketing capabilities sets us apart from our competitors in the Middle East and North Africa.

Successful research and development team

Hikma’s research and development team has particular expertise in developing technically challenging products such as injectables, complex formulations, unstable compounds and sustained release tablets and capsules.

Large and experienced sales force

Hikma’s team of more than 1600 sales and marketing representatives has helped to establish strong relationships with physicians, hospitals, pharmacies and purchasing groups for hospitals across the MENA region.

Attractive licensing partner

Hikma’s strong market position makes it the clear partner for multinational pharmaceutical companies seeking access to the fast growing MENA markets.

Strategic product development

When identifying and developing new generic pharmaceutical products, we look for products that have a strong market potential and that complement our focus on key therapeutic categories. We also strive to identify products for which we might have an Active Pharmaceutical Ingredients (API) sourcing advantage, leveraging our expertise.

Significant pipeline

We have a strong product pipeline that focuses on FDA approved and high-quality products in key therapeutic areas such as oncology, diabetes and cardiovascular diseases. At the end of H1 2011, we had a total of 165 new compounds and 282 new dosage forms and strengths pending approval.

Commitment to quality manufacturing

Our multiple manufacturing facilities provide us with the flexibility to select the most appropriate manufacturing strategy for a particular product, taking into account factors such as cost, regulatory requirements and capacity.

Flexible manufacturing strategy

Hikma’s facilities in Jordan and Saudi Arabia have been successfully inspected by the FDA, which provides us with the capability to produce products for the US market in the MENA region, at lower costs. In a market like Algeria, where regulations can restrict the range of products that can be imported, having a local manufacturing presence is essential for building our market share.